Santillan et al. measured the concentration of copeptin in the first, second and third trimesters of pregnancy in 50 pregnant women who developed preeclampsia, 54 patients experiencing normal pregnancies and 33 nonpregnant women. Here, AVP is linked to preeclampsia.